Scarica l'app Stockscreener
1.10
0.46%
0.005
Dopo l'orario di chiusura:
1.10
Precedente Chiudi:
$1.095
Aprire:
$1.09
Volume 24 ore:
554.07K
Relative Volume:
0.68
Capitalizzazione di mercato:
$80.94M
Reddito:
$311.14M
Utile/perdita netta:
$-177.97M
Rapporto P/E:
-0.4343
EPS:
-2.5329
Flusso di cassa netto:
$-20.82M
1 W Prestazione:
-5.17%
1M Prestazione:
-38.55%
6M Prestazione:
-60.85%
1 anno Prestazione:
-75.39%
Intervallo 1D:
$1.07
$1.1376
Intervallo di 1 settimana:
$1.07
$1.29
Portata 52W:
$1.04
$5.062
Health Catalyst Inc Stock (HCAT) Company Profile
Nome
Health Catalyst Inc
Settore
Industria
Telefono
801-708-6800
Indirizzo
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, TEM, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.10 | 80.58M | 311.14M | -177.97M | -20.82M | -2.5329 |
VEEV
Veeva Systems Inc
|
178.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
44.82 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
46.76 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.47 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.14 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-08-27 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-08-08 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2024-01-03 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-04-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Iniziato | Wells Fargo | Equal Weight |
| 2022-10-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Downgrade | Stifel | Buy → Hold |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-03-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-10-14 | Iniziato | BTIG Research | Buy |
| 2021-04-29 | Ripresa | JP Morgan | Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-06-18 | Iniziato | Stifel | Buy |
| 2020-06-15 | Ripresa | Evercore ISI | Outperform |
| 2020-05-15 | Iniziato | Guggenheim | Buy |
| 2020-04-21 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-04-02 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-20 | Iniziato | Raymond James | Strong Buy |
| 2019-10-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Iniziato | Evercore ISI | Outperform |
| 2019-08-19 | Iniziato | Goldman | Buy |
| 2019-08-19 | Iniziato | JP Morgan | Overweight |
| 2019-08-19 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-19 | Iniziato | SVB Leerink | Outperform |
| 2019-08-19 | Iniziato | SunTrust | Buy |
| 2019-08-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Health Catalyst Inc Borsa (HCAT) Ultime notizie
Health Catalyst, Asure Software, GitLab, Zeta Global, and SoundHound AI Shares Plummet, What You Need To Know - TradingView
Health Catalyst downgraded at Wells Fargo after Q4 results - MSN
Health Catalyst, Inc. (HCAT) cut to equal weight at Wells Fargo on prolonged revenue, margin pressure - MSN
Health Catalyst (HCAT) Q4 2025 Earnings Transcript - AOL.com
If You Invested $1,000 in Health Catalyst (HCAT) - Stock Titan
Health Catalyst, Inc. (HCAT) Cut to Equal Weight at Wells Fargo on Prolonged Revenue, Margin Pressure - Yahoo Finance
Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2025 Earnings Call Transcript - Insider Monkey
Health Catalyst (HCAT) Stock Trades Down, Here Is Why - Yahoo Finance
Health Catalyst, IncCommon stock (NQ: HCAT - The Chronicle-Journal
Wells Fargo Adjusts Outlook for Health Catalyst (HCAT) - GuruFocus
Health Catalyst stock downgraded at Wells Fargo (HCAT:NASDAQ) - Seeking Alpha
Total debt per share of Health Catalyst, Inc. – FWB:2YP - TradingView
Health Catalyst down as Piper Sandler adds to downgrades on Q2 results - MSN
HCAT Downgraded: Wells Fargo Lowers Price Target by 80% | HCAT S - GuruFocus
Health Catalyst (NASDAQ:HCAT) Earns Equal Weight Rating from Wells Fargo & Company - MarketBeat
Health Catalyst Q4 2025 Earnings: Revenue Exceeds Forecasts, Margins DeclineNews and Statistics - IndexBox
Wells Fargo Downgrades Health Catalyst to Equalweight From Overweight, Adjusts PT to $1 From $5 - marketscreener.com
Wells Fargo downgrades Health Catalyst stock rating on structural concerns By Investing.com - Investing.com India
Wells Fargo downgrades Health Catalyst stock rating on structural concerns - Investing.com
Wells Fargo downgrades Health Catalyst (HCAT) - MSN
HCAT Q4 Deep Dive: Margin Focus and Strategic Review Amid Platform Migration Pressures - Yahoo Finance
Health Catalyst 2025 Results & 2026 Outlook: Ignite Platform & Growth StrategyNews and Statistics - IndexBox
Health Catalyst (HCAT) Receives a Hold from Stephens - The Globe and Mail
Market Recap: Is Health Catalyst Inc a top pick in the sector2026 Retail & Reliable Trade Execution Plans - baoquankhu1.vn
Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Up 18.1% in February - MarketBeat
Health Catalyst Sees Increased Investment from First Light Asset Management - National Today
Health Catalyst, Inc. $HCAT is First Light Asset Management LLC's 7th Largest Position - MarketBeat
Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Net current asset value per share of Health Catalyst, Inc. – FWB:2YP - TradingView
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Health Catalyst (HCAT) - The Globe and Mail
Canaccord Genuity Keeps Their Buy Rating on Health Catalyst (HCAT) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Korro Bio (KRRO), Health Catalyst (HCAT) - The Globe and Mail
Cantor Fitzgerald Keeps Their Hold Rating on Health Catalyst (HCAT) - The Globe and Mail
Health Catalyst (HCAT) Losses Swell To US$178 Million Challenging Margin Improvement Narrative - simplywall.st
HCAT Rating Maintained as Citigroup Lowers Price Target | HCAT S - GuruFocus
Citigroup Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $1.75 - MarketBeat
Health Catalyst (HCAT) Shares Plummet After Mixed Q4 Results - GuruFocus
Health Catalyst (HCAT) Receives Analyst Rating Update from Steph - GuruFocus
HCAT: Canaccord Genuity Lowers Price Target But Maintains Buy Ra - GuruFocus
Health Catalyst (NASDAQ:HCAT) Given New $2.00 Price Target at Stephens - MarketBeat
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Health Catalyst plummets after mixed Q4; CEO declines to rule out potential sale as part of review - Seeking Alpha
Stifel Nicolaus Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $2.00 - MarketBeat
Canaccord cuts Health Catalyst stock price target on weak guidance - Investing.com Nigeria
Canaccord cuts Health Catalyst stock price target on weak guidance By Investing.com - Investing.com South Africa
Stifel cuts Health Catalyst stock price target on migration woes - Investing.com South Africa
Cantor Fitzgerald cuts Health Catalyst stock price target on turnaround uncertainty - Investing.com South Africa
Health Catalyst, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Health Catalyst Inc Azioni (HCAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.28%
5.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):